Intuitive Surgical Inc (ISRG)vsInnovative Eyewear Inc. (LUCY)
ISRG
Intuitive Surgical Inc
$370.42
-0.90%
HEALTHCARE · Cap: $139.85B
LUCY
Innovative Eyewear Inc.
$0.94
-16.70%
HEALTHCARE · Cap: $5.89M
Smart Verdict
WallStSmart Research — data-driven comparison
Intuitive Surgical Inc generates 370095% more annual revenue ($11.03B vs $2.98M). ISRG leads profitability with a 28.4% profit margin vs -272.5%. ISRG earns a higher WallStSmart Score of 66/100 (B-).
ISRG
Strong Buy66
out of 100
Grade: B-
LUCY
Hold38
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+80.4%
Fair Value
$1907.28
Current Price
$370.42
$1536.86 discount
Margin of Safety
+16.7%
Fair Value
$1.32
Current Price
$0.94
$0.38 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 33.6%
Safe zone — low bankruptcy risk
Large-cap with strong market position
Keeps 28 of every $100 in revenue as profit
18.5% revenue growth
Earnings expanding 26.5% YoY
Reasonable price relative to book value
Revenue surging 70.2% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -102.4% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : ISRG
The strongest argument for ISRG centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 28.4% and operating margin at 33.6%. Revenue growth of 18.5% demonstrates continued momentum.
Bull Case : LUCY
The strongest argument for LUCY centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 70.2% demonstrates continued momentum.
Bear Case : ISRG
The primary concerns for ISRG are PEG Ratio, P/E Ratio. A P/E of 45.2x leaves little room for execution misses.
Bear Case : LUCY
The primary concerns for LUCY are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
ISRG profiles as a growth stock while LUCY is a hypergrowth play — different risk/reward profiles.
LUCY carries more volatility with a beta of 2.71 — expect wider price swings.
LUCY is growing revenue faster at 70.2% — sustainability is the question.
ISRG generates stronger free cash flow (948M), providing more financial flexibility.
Bottom Line
ISRG scores higher overall (66/100 vs 38/100), backed by strong 28.4% margins and 18.5% revenue growth. LUCY offers better value entry with a 16.7% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Intuitive Surgical Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.
Innovative Eyewear Inc.
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Innovative Eyewear Inc. (LUCY) stands at the forefront of the smart eyewear sector, merging advanced technology with appealing aesthetics to meet the needs of modern, tech-savvy consumers. Its flagship product line, Lucyd, is designed to provide integrated audio features and seamless connectivity, offering a blend of convenience and style. Firmly focused on enhancing user experience and driving innovation, LUCY is well-positioned to leverage the growing demand for multifunctional eyewear, creating significant growth opportunities in a rapidly evolving market. As the trend towards smart, connected devices accelerates, LUCY’s strategic initiatives to promote its product offerings place it in a strong position for long-term competitiveness and success.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?